These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2270329)
41. Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2. Breslow JL; Zannis VI; SanGiacomo TR; Third JL; Tracy T; Glueck CJ J Lipid Res; 1982 Nov; 23(8):1224-35. PubMed ID: 7175379 [TBL] [Abstract][Full Text] [Related]
42. Hypertriglyceridemia and lower LDL cholesterol concentration in relation to apolipoprotein E phenotypes in myotonic dystrophy. Moorjani S; Gaudet D; Laberge C; Thibault MC; Mathieu J; Morissette J; Lupien PJ; Brun D; Gagné C Can J Neurol Sci; 1989 Feb; 16(1):129-33. PubMed ID: 2924207 [TBL] [Abstract][Full Text] [Related]
43. Direct phenotyping of human apolipoprotein E in plasma: application to population frequency distribution in Paris (France). Bailleul S; Couderc R; Landais V; Lefèvre G; Raichvarg D; Etienne J Hum Hered; 1993; 43(3):159-65. PubMed ID: 8330879 [TBL] [Abstract][Full Text] [Related]
44. Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations. Duman BS; Oztürk M; Yilmazer S; Hatemi H Diabetes Nutr Metab; 2004 Oct; 17(5):267-74. PubMed ID: 16295048 [TBL] [Abstract][Full Text] [Related]
46. Remnant-like lipoprotein particles in type 2 diabetic patients with apolipoprotein E3/3 and apolipoprotein E2 genotypes. Saito M; Eto M; Kaku K Metabolism; 2002 Aug; 51(8):964-9. PubMed ID: 12145767 [TBL] [Abstract][Full Text] [Related]
47. Distribution of apolipoprotein E phenotypes in Friedreich's ataxia. Bouthillier D; Nestruck AC; Milne R; Sing CF; Barbeau A; Davignon J Can J Neurol Sci; 1984 Nov; 11(4 Suppl):626-30. PubMed ID: 6509415 [TBL] [Abstract][Full Text] [Related]
48. Triglyceride-rich lipoproteins from apolipoprotein E3/2 subjects with hypertriglyceridemia enhance cholesteryl ester synthesis in human macrophages. Saito M; Eto M; Makino I Atherosclerosis; 1997 Feb; 129(1):73-7. PubMed ID: 9069520 [TBL] [Abstract][Full Text] [Related]
49. Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet. Tikkanen MJ; Huttunen JK; Ehnholm C; Pietinen P Arteriosclerosis; 1990; 10(2):285-8. PubMed ID: 2317162 [TBL] [Abstract][Full Text] [Related]
50. The effect of physical activity on serum total and low-density lipoprotein cholesterol concentrations varies with apolipoprotein E phenotype in male children and young adults: The Cardiovascular Risk in Young Finns Study. Taimela S; Lehtimäki T; Porkka KV; Räsänen L; Viikari JS Metabolism; 1996 Jul; 45(7):797-803. PubMed ID: 8692011 [TBL] [Abstract][Full Text] [Related]
51. Phenotypic effects of apolipoprotein structural variation on lipid profiles. III. Contribution of apolipoprotein E phenotype to prediction of total cholesterol, apolipoprotein B, and low density lipoprotein cholesterol in the healthy women study. Eichner JE; Kuller LH; Ferrell RE; Meilahn EN; Kamboh MI Arteriosclerosis; 1990; 10(3):379-85. PubMed ID: 2344296 [TBL] [Abstract][Full Text] [Related]
52. Apolipoprotein E isoforms 3/3 and 3/4 differentially interact with circulating stearic, palmitic, and oleic fatty acids and lipid levels in Alaskan Natives. Castellanos-Tapia L; López-Alvarenga JC; Ebbesson SO; Ebbesson LO; Tejero ME Nutr Res; 2015 Apr; 35(4):294-300. PubMed ID: 25727313 [TBL] [Abstract][Full Text] [Related]
53. Apolipoprotein E phenotypes, serum lipoproteins and apolipoproteins in angiographically assessed coronary heart disease. Stuyt PM; Brenninkmeijer BJ; Demacker PN; Hendriks JC; van Elteren P; Stalenhoef AF; van 't Laar A Scand J Clin Lab Invest; 1991 Sep; 51(5):425-35. PubMed ID: 1947727 [TBL] [Abstract][Full Text] [Related]
55. [Apolipoportein E polymorphism, serum lipids and apolipoproteins of 362 Han national subjects in Chengdu area]. Fan P; Zhang Z; Liu Y; Gu H; Liu B Hua Xi Yi Ke Da Xue Xue Bao; 1999 Dec; 30(4):373-4, 390. PubMed ID: 11387943 [TBL] [Abstract][Full Text] [Related]
56. Variability gene effects of DNA polymorphisms at the apo B, apo A I/C III and apo E loci on serum lipids: the Cardiovascular Risk in Young Finns Study. Porkka KV; Taimela S; Kontula K; Lehtimäki T; Aalto-Setälä K; Akerblom HK; Viikari JS Clin Genet; 1994 Mar; 45(3):113-21. PubMed ID: 7913004 [TBL] [Abstract][Full Text] [Related]
57. Lipoprotein(A) levels and apoprotein(a) phenotypes in a Sicilian population. Noto D; Barbagallo CM; Cavera G; Caldarella R; Marino G; Pace A; Notarbartolo A; Averna MR Ann Ital Med Int; 1998; 13(4):205-8. PubMed ID: 10400464 [TBL] [Abstract][Full Text] [Related]
58. Polymorphism of apolipoprotein E, lipoprotein(a), and other lipoproteins in children with type I diabetes. Salzer B; Stavljenić A; Jürgens G; Dumić M; Radica A Clin Chem; 1993 Jul; 39(7):1427-32. PubMed ID: 8330401 [TBL] [Abstract][Full Text] [Related]
59. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. Weintraub MS; Eisenberg S; Breslow JL J Clin Invest; 1987 Dec; 80(6):1571-7. PubMed ID: 3479440 [TBL] [Abstract][Full Text] [Related]
60. Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects. Cohn JS; Tremblay M; Amiot M; Bouthillier D; Roy M; Genest J; Davignon J Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):149-59. PubMed ID: 8548416 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]